Newsroom
Sorted by: Latest
-
WD to Participate in Upcoming Investor Conferences
SAN JOSE, Calif.--(BUSINESS WIRE)--Western Digital Corporation (Nasdaq: WDC) today announced management participation in the following upcoming investor conferences: Event: UBS Global Technology and AI Conference Date: Tuesday, December 1, 2026, at 11:15 a.m. PT / 2:15 p.m. ET Event: 55th Nasdaq London Investor Conference Date: Tuesday, December 8, 2026, at 7:00 a.m. PT / 10:00 a.m. ET The management presentations will be available as live webcasts, accessible through WD's Investor Relations we...
-
IQM unterstützt die Bemühungen von NVIDIA, Quantencomputer in Slurm planbar zu machen
CHICAGO--(BUSINESS WIRE)--IQM Quantum Computers (Nasdaq: IQMX), ein Weltmarktführer im Bereich supraleitender Quantencomputer, hat heute auf der SC26 in Chicago bekannt gegeben, dass das Unternehmen die Bemühungen von NVIDIA unterstützt, Quantenprozessoreinheiten (QPUs) durch die Integration von IQM-Quantencomputern zu einer planbaren Ressource im Slurm-Workload-Manager zu machen. NVIDIA, dessen erklärtes Ziel es ist, Slurm als Open-Source-Projekt und herstellerneutral verfügbar zu halten, gab...
-
Accord Announces Third Quarter Financial Results and Amendment to its Banking Facility
TORONTO--(BUSINESS WIRE)--Accord Announces Third Quarter Financial Results and Amendment to its Banking Facility...
-
OFS Credit Company Announces Preliminary Estimates of Certain Financial Results for its Fourth Fiscal Quarter 2026
CHICAGO--(BUSINESS WIRE)--OFS Credit Company, Inc. (Nasdaq: OCCI, OCCIM, OCCIN) (“OFS Credit”, the “Company”, “we”, “us” or “our”), an investment company that primarily invests in collateralized loan obligation (“CLO”) equity and debt securities, today announced preliminary estimates of certain financial results for the fiscal quarter ended October 31, 2026. PRELIMINARY ESTIMATES OF CERTAIN FINANCIAL RESULTS Management’s unaudited estimate of the range of our net asset value per share of our co...
-
Fuze Health Advances Chronic Care Through Its Technology-Led Intelligent Care Platform and Partner Collaboration
SAN FRANCISCO--(BUSINESS WIRE)--Fuze Health advances chronic care through technology-led intelligent care platform and new partner collaborations...
-
Gov. Reynolds Announces U.S. Treasury Approval of 44 Iowa Opportunity Zones
DES MOINES, Iowa--(BUSINESS WIRE)--Today, Governor Kim Reynolds announced that the U.S. Department of the Treasury has approved 44 Iowa census tracts as Qualified Opportunity Zones. The new designations will take effect January 1, 2027, and remain in place for 10 years. Opportunity Zones are economically distressed census tracts submitted by governors and certified by Treasury to encourage long-term private investment. Taxpayers who reinvest eligible capital gains through Qualified Opportunity...
-
Cognito’s Non-Invasive, At-Home Therapy, Spectris®, Showed Consistent Slowing of Cognitive and Functional Decline in Early Symptomatic Alzheimer’s Disease in HOPE Pivotal Study
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cognito’s Spectris®, Showed Consistent Slowing of Cognitive and Functional Decline in Early Symptomatic AD in HOPE Pivotal Study...
-
APPS Investors Have Opportunity to Join Digital Turbine, Inc. Fraud Investigation with SBS Law
LOS ANGELES--(BUSINESS WIRE)--APPS Investors Have Opportunity to Join Digital Turbine, Inc. Fraud Investigation with SBS Law...
-
KBRA Assigns Preliminary Ratings to New Residential Mortgage Loan Trust 2026-NQM12 (NRMLT 2026-NQM12)
NEW YORK--(BUSINESS WIRE)--KBRA assigns preliminary ratings to 10 classes of mortgage-backed notes from New Residential Mortgage Loan Trust 2026-NQM12 (NRMLT 2026-NQM12), a $493.4 million non-prime RMBS transaction sponsored by Rithm Capital Corp. (formerly New Residential Investment Corp.), a publicly traded (NYSE: RITM) real estate investment trust (REIT). The underlying mortgages in the subject pool were originated by NewRez LLC (83.4%) and Cake Mortgage Corp (12.7%). In addition, all loans...
-
FDA Approves Genentech’s WILSERDLY (Giredestrant), a Next-Generation Oral SERD, for ER-Positive, ESR1-Mutated Advanced Breast Cancer
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Wilserdly (giredestrant) is now FDA-approved for ER+, ESR1-mutated advanced breast cancer, offering a new option to help delay disease progression....